A Single-Arm, Phase II Study of the Anti-Blys Monoclonal Antibody Belimumab in Symptomatic Waldenstrom Macroglobulinemia

2013 ◽  
Vol 13 (5) ◽  
pp. 575-578 ◽  
Author(s):  
Mark Bishton ◽  
Andrew Spencer ◽  
Michael Dickinson ◽  
David Ritchie
Keyword(s):  
Monoclonal Antibody ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Waldenström Macroglobulinemia ◽  
Waldenstrom Macroglobulinemia

Multicenter prospective phase II study of venetoclax in patients with previously treated Waldenstrom macroglobulinemia

2019 ◽  
Vol 19 (10) ◽  
pp. e39-e40 ◽  
Author(s):  
Jorge Castillo ◽  
John Allan ◽  
Tanya Siddiqi ◽  
Ranjana Advani ◽  
Andrew Keezer ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Waldenström Macroglobulinemia ◽  
Waldenstrom Macroglobulinemia ◽  
Prospective Phase ◽  
Previously Treated

scholarly journals A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenström Macroglobulinemia

2012 ◽  
Vol 18 (18) ◽  
pp. 5043-5050 ◽  
Author(s):  
Irene M. Ghobrial ◽  
Philippe Moreau ◽  
Brianna Harris ◽  
Tiffany Poon ◽  
Eric Jourdan ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Single Agent ◽  
Waldenström Macroglobulinemia ◽  
Multicenter Phase ◽  
Waldenstrom Macroglobulinemia ◽  
Previously Treated

A535 Phase II Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenström Macroglobulinemia

2009 ◽  
Vol 9 ◽  
pp. S83-S84
Author(s):  
IM Ghobrial ◽  
AM Roccaro ◽  
J Matous ◽  
W Padmanabhan ◽  
A Badros ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Waldenström Macroglobulinemia ◽  
Waldenstrom Macroglobulinemia
Sign in / Sign up

Export Citation Format

Share Document